Brooke Britton,DVM, DACVIM (Oncology)
Specialist in Oncology Department: Oncology
Dr. Brooke Britton is a native New Yorker, growing up on Long Island and returning to New York City to reside after completion of her veterinary training. She obtained her veterinary degree at Cornell, and completed her residency in Medical Oncology at the University of Pennsylvania. Dr. Britton has been in clinical practice as a board-certified Diplomate of the American College of Veterinary Internal Medicine in Oncology since 2012 in New York, New Jersey, and California, the majority of those years as Head of Service for the Brooklyn and Downtown Manhattan Oncology departments of a large multi-specialty hospital network, where she was active in house officer training and clinical trials development. Dr. Britton was subsequently appointed the Director of Clinical Development for Veritas Veterinary Partners, a nationwide network of veterinary ER and specialty hospitals, where she architected and implemented clinical training and wellness initiatives within partner practices to strategically drive medical excellence and practice growth. She has lectured nationally, and is a peer-reviewed author, medical editor, and medical podcaster.
Dr. Britton joined the AMC as a Senior Veterinarian in the Cancer institute in 2023 to return to her passion for clinical practice, house officer training, and clinical research. While she provides comprehensive care for all cancer types, her particular interests lie in the treatment of hematologic malignancies, the use of small molecular inhibitor therapy and immunotherapy in veterinary cancer patients, and the multimodal treatment of metastatic cancers. Her practice philosophy is heavily quality-of-life-centered, while delivering the highest standard of oncologic care. Outside of clinical practice, Dr. Britton enjoys aerial fitness, forest bathing, travel, photography, and long strolls in NYC with her French Bulldog.
- Diplomate, American College of Veterinary Internal Medicine (Oncology)
- BA (Molecular Biology Concentration), University of Pennsylvania
- DVM, New York State College of Veterinary Medicine at Cornell University
- Rotating Internship in Medicine and Surgery and Specialty Internship in Oncology, Red Bank Veterinary Hospital (NJ)
- Residency in Medical Oncology, University of Pennsylvania
Britton BM. Drugs used for Medical Management of Mast Cell Tumors. Clinician’s Brief. 2022 July.
Britton BM. Mast cell tumors. Clinician’s Brief. 2019 Dec.
Mullin CM, Arkans MA, Sammarco CD, Vail DM, Britton BM, Vickery KR, Risbon RE, Lachowicz J, Burgess KE, Manley CA, Clifford CA. Doxorubicin chemotherapy for presumptive cardiac hemangiosarcoma in dogs. Vet Comp Oncol. 2016 Dec;14(4) e171-e183.
Britton BM, Kelleher ME, Gregor TP, Sorenmo KU. Evaluation of factors associated with prolonged hospital stay and outcome of febrile neutropenic patients receiving chemotherapy: 70 cases (1997-2010). Vet Comp Oncol. 2014 Dec; 12(4):266-76.